• Alliance A031201: Phase III Trial of Enzalutamide (NSC #766085) vs Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
  • RTOG 0815​: Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer.   
  • SWOG 0931: Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery​​
  • SWOG 1216:  Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360-788-8238. ​​​​​